22UA.DU
BioNTech SE
DusseldorfEUREQUITY
DELAYED
Last price
98.65
▲ 4.05 (4.28%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
94.55
Prev close
94.60
Day high
98.65
Day low
94.20
Volume
204
Market cap
—
P/E (TTM)
—
52W range
68.65 – 104.90
Day trading desk
Gap from prior close
-0.05%
Prior close 94.60
VWAP
96.88
+1.83% from price
Relative volume
7.16×
Unusually busy
Session range
4.72%
94.20 – 98.65
Position in range
100%
Near session high
ATR (14D)
2.85
2.89% of price
Prior day high
94.60
PDH
Prior day low
92.55
PDL
Bid / ask spread
—
Quote not published
Session volume
408
Avg 57
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+24.09%
+25.5%
1M
+22.09%
+18.4%
3M
+23.54%
+20.4%
6M
+6.02%
-5.0%
YTD
+22.39%
+10.1%
1Y
+3.79%
-16.2%
3Y
-11.84%
-86.0%
5Y
-66.91%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 22UA.DU open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.87B | $2.75B | $3.82B | $17.31B | +4.3% |
| Operating revenue | $2.87B | $2.75B | $3.82B | $17.15B | +4.3% |
| Cost of revenue | $641.80M | $541.30M | $599.80M | $3.00B | +18.6% |
| Gross profit | $2.23B | $2.21B | $3.22B | $14.32B | +0.8% |
| Research & development | $2.10B | $2.25B | $1.78B | $1.54B | -6.6% |
| Selling, general & admin | $698.20M | $712.70M | $587.10M | $541.20M | -2.0% |
| Total operating expense | $2.87B | $2.92B | $2.34B | $2.01B | -1.7% |
| Operating income | -$640.70M | -$709.40M | $875.60M | $12.30B | +9.7% |
| Net interest income | -$12.60M | -$17.20M | -$7.50M | -$18.90M | +26.7% |
| Pre-tax income | -$1.05B | -$677.70M | $1.19B | $12.95B | -55.1% |
| Tax provision | $85.30M | -$12.40M | $255.80M | $3.52B | +787.9% |
| Net income | -$1.14B | -$665.30M | $930.30M | $9.43B | -70.8% |
| Net income to common | -$1.14B | -$665.30M | $930.30M | $9.43B | -70.8% |
| Basic EPS | -4.70 | -2.77 | 3.87 | 38.78 | -69.7% |
| Diluted EPS | -4.70 | -2.77 | 3.83 | 37.77 | -69.7% |
| EBIT | -$1.04B | -$660.80M | $1.19B | $12.97B | -56.9% |
| EBITDA | -$653.80M | -$362.80M | $1.38B | $13.10B | -80.2% |
| Basic shares | 241.70M | 240.18M | 240.60M | 243.30M | +0.6% |
| Diluted shares | 241.70M | 240.18M | 242.70M | 249.80M | +0.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $7.68B | $9.76B | $11.66B | $13.88B | -21.4% |
| Cash & short-term investments | $14.88B | $16.78B | $16.55B | $14.06B | -11.4% |
| Accounts receivable | $924.20M | $1.46B | $2.16B | $7.15B | -36.9% |
| Inventory | $110.70M | $283.30M | $357.70M | $439.60M | -60.9% |
| Total current assets | $16.15B | $18.80B | $19.53B | $21.92B | -14.1% |
| Property, plant & equipment | $1.29B | $1.18B | $971.60M | $821.10M | +9.1% |
| Goodwill & intangibles | $1.97B | $1.17B | $1.17B | $219.70M | +68.6% |
| Total assets | $21.99B | $22.53B | $23.01B | $23.28B | -2.4% |
| Total current liabilities | $2.14B | $2.52B | $2.07B | $2.95B | -15.1% |
| Current debt | $52.20M | $39.50M | $28.10M | $36.00M | +32.2% |
| Long-term debt | $215.20M | $214.70M | $191.00M | $176.20M | +0.2% |
| Total debt | $267.40M | $254.20M | $219.10M | $212.20M | +5.2% |
| Total liabilities | $2.76B | $3.12B | $2.76B | $3.22B | -11.4% |
| Retained earnings | $17.96B | $19.10B | $19.76B | $18.83B | -5.9% |
| Shareholder equity | $19.22B | $19.41B | $20.25B | $20.06B | -1.0% |
| Working capital | $14.00B | $16.28B | $17.46B | $18.97B | -14.0% |
| Net tangible assets | $17.25B | $18.24B | $19.08B | $19.84B | -5.4% |
| Shares issued | 259.03M | 248.55M | 248.55M | 248.55M | +4.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$1.05B | -$677.70M | $1.19B | $12.95B | — | -55.1% |
| Depreciation & amortisation | $382.80M | $298.00M | $183.40M | $123.30M | — | +28.5% |
| Stock-based compensation | $106.20M | $100.90M | $51.40M | $108.60M | — | +5.3% |
| Change in working capital | $537.80M | $1.22B | $5.57B | $4.52B | — | -55.9% |
| Operating cash flow | $456.00M | $207.70M | $5.37B | $13.58B | — | +119.5% |
| Capital expenditure | -$749.00M | -$452.30M | -$705.50M | -$363.30M | — | -65.6% |
| Investing cash flow | -$2.47B | -$2.08B | -$6.95B | -$35.30M | — | -18.6% |
| Share buybacks | $0 | $0 | -$738.50M | -$986.40M | — | — |
| Dividends paid | — | $0 | $0 | -$484.30M | $0 | — |
| Financing cash flow | -$52.90M | -$45.90M | -$778.60M | -$1.42B | — | -15.3% |
| Free cash flow | -$293.00M | -$244.60M | $4.67B | $13.21B | — | -19.8% |
| End cash position | $7.68B | $9.76B | $11.66B | $13.88B | — | -21.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $105.60M | $118.10M | $907.40M | $1.52B | $260.80M | -10.6% |
| Operating revenue | $51.90M | $66.90M | $1.12B | $1.47B | $153.30M | -22.4% |
| Cost of revenue | $97.00M | $71.40M | $333.30M | $148.30M | $76.40M | +35.9% |
| Gross profit | $8.60M | $46.70M | $574.10M | $1.37B | $184.40M | -81.6% |
| Research & development | $551.00M | $557.00M | $505.40M | $564.80M | $509.10M | -1.1% |
| Selling, general & admin | $197.80M | $163.80M | $291.70M | $148.50M | $137.40M | +20.8% |
| Total operating expense | $947.30M | $717.90M | $854.60M | $716.70M | $656.40M | +32.0% |
| Operating income | -$938.70M | -$671.20M | -$280.50M | $653.90M | -$472.00M | -39.9% |
| Net interest income | $62.70M | $57.00M | -$5.10M | -$300.00K | $64.00M | +10.0% |
| Pre-tax income | -$858.70M | -$568.10M | -$227.40M | $24.70M | -$402.70M | -51.2% |
| Tax provision | -$37.90M | -$36.20M | $77.60M | $53.40M | -$16.10M | -4.7% |
| Net income | -$820.80M | -$531.90M | -$305.00M | -$28.70M | -$386.60M | -54.3% |
| Net income to common | -$820.80M | -$531.90M | -$305.00M | -$28.70M | -$386.60M | -54.3% |
| Basic EPS | -3.24 | -2.10 | -1.25 | -0.12 | -1.60 | -54.3% |
| Diluted EPS | -3.24 | -2.10 | -1.25 | -0.12 | -1.60 | -54.3% |
| EBIT | -$855.20M | -$564.10M | -$676.40M | $653.90M | -$399.00M | -51.6% |
| EBITDA | -$589.10M | -$442.80M | -$511.60M | $778.10M | -$348.00M | -33.0% |
| Basic shares | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M | +0.0% |
| Diluted shares | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M | +0.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.74B | $9.94B | $7.68B | $10.09B | $10.27B | -2.0% |
| Cash & short-term investments | $14.78B | $14.64B | $14.88B | $14.52B | $14.04B | +1.0% |
| Accounts receivable | $163.90M | $539.20M | $924.20M | $690.80M | $1.37B | -69.6% |
| Inventory | $100.60M | $103.80M | $110.70M | $225.70M | $230.70M | -3.1% |
| Total current assets | $15.30B | $15.53B | $16.15B | $15.83B | $15.93B | -1.5% |
| Property, plant & equipment | $1.22B | $1.32B | $1.29B | $1.24B | $1.24B | -7.6% |
| Goodwill & intangibles | $1.79B | $1.92B | $1.97B | $1.75B | $1.85B | -6.4% |
| Total assets | $20.34B | $21.07B | $21.99B | $21.34B | $21.64B | -3.5% |
| Total current liabilities | $1.95B | $1.76B | $2.14B | $2.22B | $1.85B | +10.4% |
| Current debt | $57.20M | $10.80M | $52.20M | $53.40M | $52.40M | +429.6% |
| Long-term debt | $258.90M | $66.60M | $215.20M | $192.00M | $217.20M | +288.7% |
| Total debt | $316.10M | $302.80M | $267.40M | $245.40M | $269.60M | +4.4% |
| Total liabilities | $2.59B | $2.38B | $2.76B | $2.86B | $3.13B | +8.8% |
| Retained earnings | $16.61B | $17.43B | $17.96B | $18.27B | $18.30B | -4.7% |
| Shareholder equity | $17.76B | $18.70B | $19.22B | $18.48B | $18.51B | -5.0% |
| Working capital | $13.35B | $13.77B | $14.00B | $13.61B | $14.08B | -3.0% |
| Net tangible assets | $15.96B | $16.78B | $17.25B | $16.73B | $16.65B | -4.9% |
| Shares issued | 251.20M | 259.03M | 259.03M | 248.55M | 248.55M | -3.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$858.70M | -$568.10M | -$227.40M | $24.70M | -$402.70M | — | -51.2% |
| Depreciation & amortisation | $266.10M | $121.30M | $164.80M | $124.20M | $51.00M | — | +119.4% |
| Stock-based compensation | $20.90M | $22.80M | $24.10M | $27.90M | $32.10M | — | -8.3% |
| Change in working capital | $593.90M | $66.20M | -$227.40M | $644.00M | $519.70M | — | +797.1% |
| Operating cash flow | $10.50M | -$421.00M | $309.50M | $780.70M | $146.50M | — | +102.5% |
| Capital expenditure | -$55.40M | -$78.90M | -$62.10M | -$38.60M | -$30.20M | — | +29.8% |
| Investing cash flow | -$100.10M | $2.65B | -$2.73B | -$925.30M | -$64.40M | — | -103.8% |
| Share buybacks | -$129.20M | — | — | — | $0 | $0 | — |
| Financing cash flow | -$108.50M | $26.40M | -$14.30M | -$11.50M | -$13.30M | — | -511.0% |
| Free cash flow | -$44.90M | -$499.90M | $247.40M | $742.10M | $116.30M | — | +91.0% |
| End cash position | $9.74B | $9.94B | $7.68B | $10.09B | $10.27B | — | -2.0% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
84.68
+16.49% from price
SMA 20
82.23
+19.96% from price
SMA 50
81.15
+21.56% from price
SMA 100
81.14
+21.59% from price
SMA 200
83.86
+17.63% from price
EMA 12
86.19
+14.46% from price
EMA 26
83.21
+18.56% from price
EMA 50
81.88
+20.48% from price
RSI (14)
80.3
Overbought
MACD (12,26,9)
2.98
Hist 2.02
ATR (14)
2.85
2.89% of price
Realised vol 30D
55.5%
Annualised
Bollinger upper
94.06
20, 2σ
Bollinger lower
70.41
20, 2σ
50 / 200 cross
Death
81.15 vs 83.86
Trend bias
Above 200
+17.63%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.09
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
55.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-28.6%
Peak to trough
Max drawdown 5Y
-77.9%
Peak to trough
ATR 14
2.85
2.89% of price
Beta (reported)
—
5Y monthly, from filing
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 5, 26 | Citigroup | MAINTAINED | Buy | Buy |
| Aug 5, 26 | Evercore ISI Group | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| May 27, 26 | UBS | UPGRADE | Neutral | Buy |
| May 22, 26 | Bernstein | INITIATED | — | Market Perform |
| May 6, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
| May 6, 26 | Wells Fargo | MAINTAINED | Overweight | Overweight |
| Apr 27, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 10, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Mar 31, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 11, 26 | Morgan Stanley | MAINTAINED | Overweight | Overweight |
| Mar 11, 26 | Canaccord Genuity | MAINTAINED | Buy | Buy |
Headlines
The Custodial Account You Opened for Your Grandson Becomes Legally His the Day He Turns 21, and He Can Spend It on a Car. A 529 Never Does.
24/7 Wall St. · 6m ago
This Company Just Paid Out $6.8 Billion. Its AI Bill Was 4x That
24/7 Wall St. · 11m ago
Trump takes starring role at Washington's IndyCar debut
AFP · 12m ago
If a Bear Market Is Coming, Here's What All of the Smartest Investors Are Doing Right Now
Motley Fool · 15m ago
Sen. Scott calls Darline Graham 'real deal' after debate-stage gaffe
USA TODAY · 23m ago
UBS revamps S&P 500 target for rest of 2026
TheStreet · 27m ago
Better Dividend King to Buy Right Now: Abbott Labs or Johnson & Johnson?
Motley Fool · 30m ago
Macron hosts Saudi crown prince for visit ranging from esports to Mideast
AFP · 32m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.